ORAL SESSION
Friday, 4/10/2024, 11.15 – 13.15
HALL B
(A Committee will select the best oral presentation)
Abstract 51
PREVALENCE AND DETERMINANTS OF UPPER GI ENDOSCOPY IN NORTHERN ITALY
Benzoni I.*[1], Martinelli L.[2], Bonafede M.[1], Lugo A.[3], Gallus S.[3], Possenti I.[3], Baiocchi G.L.[4], Verlato G.[5]
[1]General Surgery Unit, ASST Cremona ~ Cremona ~ Italy, [2]Unit of clinical & Evaluative Epidemiology, APSS, Trento, Italy ~ Trento ~ Italy, [3]Department of Medical Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy ~ Milano ~ Italy, [4]Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy ~ Brescia ~ Italy, [5]Unit of Epidemiology & Medical Statistics, Dept. of Diagnostics & Public Health, University of Verona, Italy ~ Verona ~ Italy
Abstract 13
SHORTENING THE GAP BETWEEN EAST AND WEST IN LAPAROSCOPIC GASTRECTOMY FOR GASTRIC CANCER: DATA FROM THE “ITALIAN SIDE” INSTITUTIONS ON BEHALF OF THE ITALIAN RESEARCH GROUP FOR GASTRIC CANCER (GIRCG)
Lombardi P.M.*[1], Giovanni Ferrari*[1], Gualtierotti M.[1], Giacopuzzi S.[2], Rosati R.[3], Fumagalli Romario U.[4], Degiuli M.[5], Rausei S.[11], Baiocchi G.L.[6], Biondi A.[7], Marchesi F.[8], Molfino S.[9], Olmi S.[10], Solaini L.[12], Staderini F.[13], Viganò J.[14], Garulli G.[15], Oldani M.[16], Milone M.[17]
[1]Minimally Invasive Surgical Oncology Unit – Niguarda Cancer Center, Niguarda Hospital ~ Milan ~ Italy, [2]Department of General and Upper GI Surgery – University of Verona ~ Verona ~ Italy, [3]Department of Gastrointestinal Surgery – San Raffaele Research Hospital ~ Milan ~ Italy, [4]Digestive Surgery – European Institute of Oncology, IRCSS ~ Milan ~ Italy, [5]Surgical Oncology and Digestive Surgery Unit – San Luigi University Hospital ~ Orbassano ~ Italy, [6]General Surgery – ASST Cremona ~ Cremona ~ Italy, [7]Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS ~ Rome ~ Italy, [8]Unit of General Surgery, University Hospital ~ Parma ~ Italy, [9]Department of Clinical and Experimental Sciences, University of Brescia and Third Division of General Surgery, Brescia Civili Hospital ~ Brescia ~ Italy, [10]General and Oncologic Surgery – Policlinico San Marco ~ Zingonia ~ Italy, [11]General Surgery Unit – Department of Surgery, Cittiglio-Angera Hospital, ASST Sette Laghi ~ Varese ~ Italy, [12]Department of Medical and Surgical Sciences – University of Bologna, Morgagni-Pierantoni Hospital ~ Forlì ~ Italy, [13]Digestive Surgery Unit, Department of Clinical and Experimental Medicine, Careggi University Hospital of Florence ~ Florence ~ Italy, [14]General Surgery – Department of Surgery, Fondazione IRCCS Policlinico San Matteo ~ Pavia ~ Italy, [15]General Surgery Unit, Infermi Hospital ~ Rimini ~ Italy, [16]General Surgery Unit, Foundation IRCCS San Gerardo dei Tintori ~ Monza ~ Italy, [17]Department of Clinical Medicine and Surgery, Federico II University of Naples ~ Naples ~ Italy
Abstract 50
POSTOPERATIVE OUTCOMES AFTER OPEN VERSUS MINIMALLY INVASIVE GASTRECTOMY FOR GASTRIC CANCER: A EUROPEAN MULTICENTER STUDY BASED ON THE GASTRODATA REGISTRY
Bencivenga M.[1], Kaywani K.[3], Torroni L.[2], Filippini F.*[1], Giacopuzzi S.[1], Verlato G.[2], Hoelscher A.[4], D”Ugo D.[5], Piessen G.[6], Wijnhoven B.[7], Schneider P.[8], Pera M.[9], Fumagalli Romario U.[10], Kolodziejczyk P.[11], Rawicz–Pruszynski K.[12], Van Sandick J.[13], Lara Santos L.[14], Allum W.[15], Rosati R.[16], Davies A.[17], Reim D.[18], Moenig S.[19], Gockel I.[20], Baiocchi G.L.[21], Da Costa P.M.[22], Reddavid R.[23], Kielan W.[24], Van Berge Henegouwen M.[3], De Manzoni G.[1], Morgagni P.[25], Gisbertz S.[3]
[1]Department of General and Upper Gi Surgery, University of Verona ~ Verona ~ Italy, [2]Unit Of Epidemiology And Medical Statistics, Department Of Diagnostics And Public Health, University Of Verona ~ Verona ~ Italy, [3]Department Of Surgery, Amsterdam UMC location University Of Amsterdam ~ Amsterdam ~ Netherlands, [4]Center For Esophageal And Gastric Cancer Surgery, Agaplesion Markushospital Frankfurt ~ Frankfurt ~ Germany, [5]General Surgery Unit, Department Of Surgery, Gemelli, Catholic University Of Rome ~ Rome ~ Italy, [6]epartment Of Digestive And Oncological Surgery, Chu Lille, Claude Huriez University Hospital ~ Lille ~ France, [7]Department Of General Surgery, Erasmus Medical Center ~ Rotterdam ~ Netherlands, [8]Department Of Infectious Diseases And Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Corporate Member Of Freie Universität Berlin, Humboldt-Universität Zu Berlin, And Berlin Institute Of Health ~ Berlin ~ Germany, [9]Department Of Surgery, Hospital Del Mar, Universitat Autònoma De Barcelona, Hospital Del Mar Medical Research Institute ~ Barcelona ~ Spain, [10]Digestive Surgery, European Institute Of Oncology Irccs ~ Milan ~ Italy, [11]Department Of Surgery Jagiellonian University Medical College ~ Krakow ~ Poland, [12]Department Of Surgical Oncology, Medical University Of Lublin ~ Lublin ~ Poland, [13]Department Of Surgical Oncology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital ~ Amsterdam ~ Netherlands, [14]Experimental Pathology And Therapeutics, Research Center, Portuguese Oncology Institute; Department Of Surgical Oncology, Portuguese Oncology Institute ~ Lisbon ~ Portugal, [15]The Royal Marsden Nhs Foundation Trust ~ London ~ United Kingdom, [16]Department Of Gastrointestinal Surgery, San Raffaele Research Hospital ~ Milan ~ Italy, [17]Department Of Upper Gastrointestinal And General Surgery, Guy’s And St Thomas; Hospital,School Of Cancer And Pharmaceutical Sciences, King’s College ~ London ~ United Kingdom, [18]Department Of Surgery, Tum School Of Medicine, Technical University Of Munichpartment Of Upper Gastrointestinal And General Surgery ~ Munich ~ Germany, [19]Service De Chirurgie Viscéral, Hôpitaux Universitaires De Genève ~ Geneve ~ Switzerland, [20]Department Of Visceral, Transplant, Thoracic And Vascular Surgery, University Medical Center Of Leipzig ~ Leipzig ~ Germany, [21]General Surgery Asst Cremona, General Surgery Department Of Clinical And Experimental Sciences, University Of Brescia ~ Brescia ~ Italy, [22]General Surgery Department, Hospital Garcia De Orta, University Of Lisbon ~ Lisbon ~ Portugal, [23]University Of Turin, Department Of Oncology, Division Of Surgical Oncology And Digestive Surgery, San Luigi University Hospital ~ Turin ~ Italy, [24]Department Of General Surgery And Surgical Oncology, Wroclaw Medical University ~ Wroclaw ~ Poland, [25]Department Of General Surgery, Morgagni-Pierantoni Hospital ~ Forlì ~ Italy
Abstract 77
GASTRIC RESECTION AFTER NEOADJUVANT THERAPY: COMPARISON OF SHORT TERM AND ONCOLOGICAL OUTCOMES OF ROBOTIC AND OPEN GASTRECTOMY FROM A SINGLE CENTER
Giuliani G.G.*, Guerra F., Tribuzi A., De Franco L., Di Marino M., Coratti A.
General and Emergency Surgery Unit – Azienda USL Toscana Sud Est ~ Grosseto ~ Italy
Abstract 28
OUTCOMES OF SURGICAL TREATMENT FOR GASTRIC CANCER PATIENTS: 18-YEAR EXPERIENCE OF A TURKISH HIGH-VOLUME CENTER
Alltinsoy Ezgi, Ünal A.E.*, Binarbasi C., Baspinar A., Cebeci E., Çulcu S., Demirci S.
Ankara University Faculty of Medicine ~ Ankara ~ Turkey
————-
Abstract 10
EVALUATION OF EXOCRINE PANCREATIC INSUFFICIENCY (EPI) AND THEIR RELATIONSHIP WITH QUALITY OF LIFE (QOL) AFTER GASTRECTOMY FOR GASTRIC CANCER. PRELIMINARY RESULTS.
Biffoni B.[1], Fiorillo C.*[1], Rosa F.[1], Quero G.[1], Gambaro E.[2], Di Cesare L.[2], Alfieri S.[1]
[1]Digestive Surgery Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS ~ Rome ~ Italy, [2]Università Cattolica del Sacro Cuore ~ Rome ~ Italy
Abstract 5
SURVIVAL PROGNOSTIC IMPACT OF POST-SURGICAL COMPLICATIONS IN GASTRIC CANCER PATIENTS AFTER NEOADJUVANT CHEMOTHERAPY: A SINGLE WESTERN CENTRE ANALYSIS
Graziosi L.*, Natalizi N., Longaroni M., Donini A.
University Of Perugia ~ Perugia ~ Italy
Abstract 74
ANALYSIS AND IDENTIFICATION OF PROGNOSTIC FACTORS FOR NON-CARDIA GASTRIC CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY AND RADICAL SURGERY: A MULTICENTRIC STUDY
Piccioni S.*[2], Marrelli D.[2], Morgagni P.[1], Bencivenga M.[1], Cossu A.[1], Gualtierotti M.[1], Graziosi L.[1], Gelmini R.[1], Rosa F.[1], Ministrini S.[1], Fumagalli U.[1], Orsenigo E.[1], Cianchi F.[1], Viganò J.[1], Berselli M.[1], Reddavid R.[1], Rausei S.[1], Ercolani G.[1], De Manzoni G.[1], Roviello F.[2]
[1]GIRCG Scientific secretary: department of medicine, surgery and neurosciences, university of Siena, policlinico Le Scotte, Siena, Italy ~ Siena ~ Italy, [2]Unit of general surgery and surgical oncology, department of medicine, surgery and neurosciences, university of Siena, policlinico ” Le Scotte”, Siena, Italy, GIRCG scientific secretary: department of medicine, surgery and neurosciences, Siena ~ Siena ~ I
Abstract 14
MONITORING IMMUNE STATUS PROFILES DURING ONCOLOGICAL AND SURGICAL TREATMENT IN LOCALLY ADVANCED GASTRIC CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY
Molinari C.*[1], Derventzi A.[8], Bulgarelli J.[2], Rebuzzi F.[1], Camara R.[1], Kokala–Dimitropoulou V.[9], Petracci E.[4], Prascevic D.[3], Ewald J.[3], Ulivi P.[1], Monti M.[6], Tamberi S.[7], Ercolani G.[5], Konstadoulakis M.[9], Morgagni P.[5]
[1]IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Biosciences Laboratory -Translational Oncology- ~ Meldola ~ Italy, [2]IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, Italy, Immunotherapy Cell Therapy and Biobank (ITCB) Unit, ~ Meldola ~ Italy, [3]Leipzig University, Center for Scalable Data Analytics and Artificial Intelligence (ScaDS.AI) Dresden/Leipzig ~ Leipzig ~ Germany, [4]IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” (IRST) IRCCS, Meldola, Italy, Unit of Biostatistics and Clinical Trials ~ Meldola ~ Italy, [5]Ospedale “Morgagni – Pierantoni”, General and Oncologic Surgery ~ Forlì ~ Italy, [6]IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Department of Medical Oncology ~ Meldola ~ Italy, [7]S. Maria delle Croci Hospital, Oncology Department ~ Ravenna ~ Italy, [8]National and Kapodistrian University of Athens,1st Department of Propaedeutic Surgery, Laboratory of Surgical Translational Research ~ Athen ~ Greece, [9]Aretaieion Hospital, National & Kapodistrian University of Athens, 2nd Department of Surgery ~ Athens ~ Greece
Abstract 4
PRIMARY BILE ACIDS MEDIATED FXR AGONISM PROMOTES IMMUNE-ESCAPE IN INTESTINAL TYPE OF GASTRIC CANCER (GC)
Di Giorgio C.*, Natalizi N., Graziosi L., Donini A., Fiorucci S.
University of Perugia ~ Perugia ~ Italy
Abstract 39
GASTRIC CANCER WITH MONOALLELIC MUTYH MUTATION
Soeiro Dos Reis Neves F.R.*, Soares Tomás A.R.
Portuguese Oncology Institute of Coimbra ~ Coimbra ~ Portugal
Abstract 41
OLIGOMETASTATIC GASTRIC AND JUNCTIONAL CANCER, WHERE WE ARE AND FUTURE PROSPECTS: REFLECTIONS ON THE EXPERIENCE OF A HIGH-VOLUME CENTER
Battaglia S.*, Sbacco V., Liscia N., Longo M.C., Mazza E., Carresi A., Puccetti F., Cossu A., Elmore U., Rosati R.
IRCCS San Raffaele Hospital ~ Milan ~ Italy
Abstract 19
PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY FOR THE TREATMENT OF GASTRIC CANCER PERITONEAL CARCINOMATOSIS IN A TERTIARY REFERRAL CENTER: FEASIBILITY AND SAFETY IN BIDIRECTIONAL TREATMENT SETTING
Calef R., Carresi A., Cossu A.*, Battaglia S., Puccetti F., Barbieri L., Cinelli L., Treppiedi E., Gozzini L., Mazza E., Elmore U., Rosati R.
IRCCS San Raffaele Scientific Institute ~ Milan ~ Italy
Abstract 27
STAGING AND TREATMENT OF GASTRIC NEUROENDOCRINE TUMORS: A SINGLE CENTER EXPERIENCE
Fumagalli Romario U.*[1], Bertani E.[1], Realis Luc M.[1], Pisa E.[2], Spada F.[3], Fazio N.[3], Giunta M.[4], Ravizza D.[4]
[1]Digestive Surgery- European Institute of Oncology – IRCCS ~ Milano ~ Italy, [2]Pathology – European Institute of Oncology – IRCCS ~ Milano ~ Italy, [3]Medical Oncology – European Institute of Oncology – IRCCS ~ Milano ~ Italy, [4]Endoscopy – European Institute of Oncology – IRCCS ~ Milano ~ Italy
Treatment of early forms
Abstract 59
ASSESSMENT OF QUALITY OF LIFE AFTER TOTAL GASTRECTOMY IN CDH1 VARIANT CARRIERS
Aaltonen G., Louhimo J.*, Juuti A., Kokkola A.
Helsinki University Hospital ~ Helsinki ~ Finland
Treatment of clinical stage I/II 8